Modified Release Technology Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Altus Formulation Inc.: Cadila Pharmaceuticals and Altus Formulation Announce Successful Clinical Studies with TramaFlex Breakable Extended-Release Tablets
tm Modified Release Technology Platform:
New Safer to Use Value Added Tablets
AHMEDABAD, INDIA and LAVAL, QC / ACCESSWIRE / January 27, 2021 / Cadila Pharmaceuticals Limited (
Cadila ) and
Altus ) today announced the successful completion of human clinical studies with TramaFlex
TM breakable extended-release (ER) tablets, a novel value-added once-daily formulation of tramadol hydrochloride for the improved treatment of patients with moderate to moderately severe pain.
Developed by Altus using proprietary AmyloFlex
TM technology, human bio-equivalence studies conducted by Cadila demonstrated TramaFlex ER tablets are bio-equivalent to 24hr ER products available commercially in North America, Europe, and Asia. Unlike marketed brands that can rapidly release their entire contents if damaged, with ....

United States , M Robert Bechard , Kostenloser Wertpapierhandel , Damon Smith , Cadila Pharmaceuticals Limited , Corporate Development , Technology Platform , Altus Formulation Inc , Cadila Pharmaceuticals Ltd , Cadila Pharmaceuticals , Successful Validation , Modified Release Technology Platform , New Safer , Use Value Added , Altus Formulation , North America , Rajiv Modi , Robert Bechard , ஒன்றுபட்டது மாநிலங்களில் , மீ ராபர்ட் பெச்சார்ட் , டாமன் ஸ்மித் , காடிலா மருந்துகள் வரையறுக்கப்பட்டவை , பெருநிறுவன வளர்ச்சி , தொழில்நுட்பம் நடைமேடை , அல்டஸ் உருவாக்கம் இன்க் , காடிலா மருந்துகள் லிமிடெட் ,